The global excipients market size was estimated at USD 10,690.68 million in 2025 and is projected to reach USD 14,746.68 million by 2033, growing at a CAGR of 4.11% from 2026 to 2033. The industry is witnessing steady growth due to the increasing demand for advanced pharmaceutical formulations, rising production of generic medicines, and expanding global healthcare infrastructure. Excipients play a critical role in pharmaceutical manufacturing by improving the stability, bioavailability, safety, and effectiveness of drug formulations. Pharmaceutical companies are increasingly utilizing advanced excipient technologies to enhance drug delivery performance, improve patient compliance, and optimize manufacturing efficiency. The growing prevalence of chronic diseases, aging populations, and increasing healthcare expenditure worldwide are further contributing to the rising demand for pharmaceutical products and associated excipient solutions.

Excipients are increasingly valued for enhancing drug functionality and offering a competitive edge in formulations, driving their widespread adoption among pharmaceutical companies. These inactive ingredients support essential pharmaceutical functions such as drug absorption, tablet binding, controlled release, coating, preservation, and taste masking. Modern pharmaceutical manufacturers are focusing on developing innovative formulations that improve therapeutic effectiveness, dosage convenience, and product stability. As a result, excipients are becoming increasingly important in supporting advanced drug delivery systems, biologics, personalized medicine, and complex pharmaceutical formulations. In addition, the rising demand for orally disintegrating tablets, sustained release formulations, and pediatric medicines is encouraging the development of multifunctional excipient technologies.

Download a free sample copy of the Excipients market report to understand detailed coverage and inclusions in the final report

Key Market Trends & Insights

• Europe excipients market held the largest share of 37.21% of the global market in 2025. The region maintains a leading position due to the strong presence of pharmaceutical manufacturing companies, advanced healthcare infrastructure, and extensive research and development activities. European countries continue to invest heavily in pharmaceutical innovation, biologics development, and specialty drug manufacturing, which supports the demand for advanced excipient solutions. In addition, stringent regulatory standards regarding pharmaceutical quality and formulation performance are encouraging the adoption of high quality excipients across the region.
• The excipients industry in the U.K. is expected to grow significantly over the forecast period. The country’s expanding pharmaceutical research activities, increasing production of generic medicines, and strong biotechnology sector are contributing to the growth of the excipients industry. Pharmaceutical manufacturers in the United Kingdom are increasingly focusing on innovative drug delivery systems, patient centric formulations, and advanced oral dosage technologies, creating favorable opportunities for excipient suppliers. Investments in pharmaceutical manufacturing infrastructure and clinical research activities are also expected to strengthen industry expansion in the country.
• By product, polymers held the highest market share of 45.66% in 2025. The dominance of the polymer segment is attributed to its extensive use in controlled release formulations, tablet coatings, bioavailability enhancement, and drug stabilization applications. Pharmaceutical polymers offer excellent flexibility, compatibility, and performance characteristics, making them essential components in modern drug delivery systems. Increasing demand for modified release formulations, biologics, and specialty pharmaceuticals continues to support the strong adoption of polymer based excipients across the pharmaceutical industry.
• By function, binders held the highest market share of 13.08% in 2025. Binders play a vital role in maintaining tablet integrity, improving compressibility, and ensuring consistent drug dosage during pharmaceutical manufacturing processes. The increasing production of solid oral dosage forms, including tablets and capsules, is significantly contributing to the demand for pharmaceutical binders. Manufacturers are increasingly utilizing advanced binder technologies to improve tablet strength, dissolution characteristics, and manufacturing efficiency across large scale pharmaceutical production environments.
• By formulation, the oral formulation segment held the highest market share of 55.66% in 2025. Oral dosage forms remain the most widely preferred method of drug administration due to their convenience, cost effectiveness, patient compliance, and ease of manufacturing. Pharmaceutical companies continue to focus on developing innovative oral formulations with improved bioavailability, taste masking, and controlled release properties. The increasing demand for oral solid dosage forms across therapeutic categories such as cardiovascular diseases, diabetes, oncology, and infectious diseases is further driving the growth of excipients used in oral formulations.
• The growing focus on biologics, personalized medicine, and advanced therapeutic products is also influencing the future development of the excipients industry. Manufacturers are increasingly developing specialized excipients capable of supporting complex formulations, targeted drug delivery, and enhanced product stability. The integration of nanotechnology, advanced material science, and pharmaceutical engineering is expected to create new opportunities for excipient innovation over the coming years.

Looking for more specific insights? Customize this report to suite your business needs

Key Companies & Market Share Insights

Eastman Chemical Corporation, P&G Chemicals, and Avantor Performance Materials, LLC are actively strengthening the market through continuous innovation in functional ingredients that enhance drug stability, solubility, and bioavailability. Companies such as Huntsman Corporation and BASF SE are expanding their pharmaceutical excipient portfolios by investing in high-performance materials and advanced formulation technologies tailored for complex drug delivery systems. Ashland Inc. and Lubrizol Corporation are focusing on polymer-based excipients and controlled-release solutions, supporting the development of next-generation oral and topical dosage forms.

Meanwhile, FMC Corporation leverages its expertise in specialty chemistries to contribute to excipient innovation, particularly in enhancing formulation efficiency and product consistency. Roquette continues to expand its plant-based excipient offerings, addressing the rising demand for natural and sustainable pharmaceutical ingredients, while Colorcon Inc. plays a critical role in film coatings and modified-release technologies that improve drug performance and patient compliance. Collectively, these companies are driving advancements in excipient functionality, scalability, and regulatory compliance, supporting the evolving needs of modern pharmaceutical development.

Key Excipients Companies:

• Eastman Chemical Corporation
• P&G Chemicals
• Avantor Performance Materials, LLC
• Huntsman Corporation
• BASF SE
• Ashland Inc.
• FMC Corporation
• Roquette
• Colorcon Inc.
• Lubrizol Corporation

Explore Grand View Horizon to see global and regional level statistics related to the Excipients Market

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making
• And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering